Halozyme Therapeutics (HALO) Net Equity Issued and Repurchased (2009 - 2026)
Halozyme Therapeutics (HALO) posted Net Equity Issued and Repurchased of $14.05 million for FY2022, up 12.1% from $12.54 million in FY2021.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
Since FY2009, Halozyme Therapeutics has reported Net Equity Issued and Repurchased for 14 years.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -36.4% (FY2017 to FY2022).
- Annual Net Equity Issued and Repurchased has run from a low of $12.54 million in FY2021 to a high of $63.39 million in FY2020 over five years.
- Business Quant data shows HALO's Net Equity Issued and Repurchased at $12.54 million in FY2021 (-80.2%), $63.39 million in FY2020 (+345.7%), $14.22 million in FY2019 (+3.7%) and $13.72 million in FY2018 (-89.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Halozyme Therapeutics | 11.73 Bn | 9.97 Bn | 410.50 Mn | -44.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -44.47 Mn |
| Jun 30, 2026 | 6.48 Mn |
| Mar 31, 2026 | -1.61 Mn |
| Dec 31, 2025 | 4.15 Mn |
| Sep 30, 2025 | -22.40 Mn |
| Jun 30, 2025 | 4.52 Mn |
| Mar 31, 2025 | -3.32 Mn |
| Dec 31, 2024 | -246.42 Mn |
| Sep 30, 2024 | 18.56 Mn |
| Jun 30, 2024 | 9.48 Mn |
| Mar 31, 2024 | -489,000.00 |
| Dec 31, 2023 | -249.92 Mn |
| Sep 30, 2023 | 4.10 Mn |
| Jun 30, 2023 | 2.45 Mn |
| Mar 31, 2023 | -151.13 Mn |
| Dec 31, 2022 | 6.97 Mn |
| Sep 30, 2022 | -197.37 Mn |
| Jun 30, 2022 | 3.82 Mn |
| Mar 31, 2022 | 624,000.00 |
| Dec 31, 2021 | -156.01 Mn |
API Access
Halozyme Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();